Cargando…

Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway

The Hippo signaling pathway plays a crucial role in regulating tissue homeostasis, organ size, tumorigenesis and cancer chemoresistance when deregulated. Physiologically, the Hippo core kinase cassette that consists of mamma-lian STE20-like protein kinase 1/2 (MST1/2), and large tumour suppressor 1/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Meiyuan, Wang, Min, Xu, Simiao, Guo, Xingjun, Jiang, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792569/ https://www.ncbi.nlm.nih.gov/pubmed/26561204

Ejemplares similares

Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer
por: Liu, Gongpan, et al.
Publicado: (2020)

Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
por: Zhao, Lifen, et al.
Publicado: (2016)

Upregulation of miR-181a impairs hepatic glucose and lipid homeostasis
por: Du, Xiliang, et al.
Publicado: (2017)

Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a
por: Suresh Babu, Vishnu, et al.
Publicado: (2022)

Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma
por: Pozzo, Enrico, et al.
Publicado: (2021)

CircSEC24A upregulates TGFBR2 expression to accelerate pancreatic cancer proliferation and migration via sponging to miR-606
por: Chen, Yankun, et al.
Publicado: (2021)

Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma
por: Wang, Hongjun, et al.
Publicado: (2015)

miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP
por: Huang, Wei, et al.
Publicado: (2019)

MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010)

Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5
por: Lu, Xu, et al.
Publicado: (2021)

miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
por: Wang, Xiaoyuan, et al.
Publicado: (2018)

miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
por: Zhang, Xin, et al.
Publicado: (2018)

lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy
por: Wang, Lei, et al.
Publicado: (2021)

miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1
por: Tian, She, et al.
Publicado: (2016)

miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
por: Xu, Manman, et al.
Publicado: (2018)

Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype
por: Jiang, Jianxin, et al.
Publicado: (2014)

Hemorrhagic Stroke Induces a Time-Dependent Upregulation of miR-150-5p and miR-181b-5p in the Bloodstream
por: Cepparulo, Pasquale, et al.
Publicado: (2021)

miR-181a-regulated pathways in T-cell differentiation and aging
por: Kim, Chulwoo, et al.
Publicado: (2021)

Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway
por: Que, Kaiqian, et al.
Publicado: (2017)

TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
por: Wang, Bo, et al.
Publicado: (2009)

Upregulating miR-181b promotes ferroptosis in osteoarthritic chondrocytes by inhibiting SLC7A11
por: Wang, Dexin, et al.
Publicado: (2023)

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Henriques, Daniel G., et al.
Publicado: (2023)

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
por: Copier, Camila Uribe, et al.
Publicado: (2017)

Expressions of miR-155 and miR-181 and predictions of their structures and targets in pigs (Sus scrofa)
por: Ninsuwon, Jirapat, et al.
Publicado: (2020)

Diagnosis value of miR‐181, miR‐652, and CA72‐4 for gastric cancer
por: Tian, Wenyan, et al.
Publicado: (2022)

Expression Patterns of miR181a and miR30d in Patients with Breast Cancer
por: Tavakolpournegari, Alireza, et al.
Publicado: (2022)

Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
por: Simiene, Julija, et al.
Publicado: (2023)

miR-181 suppresses metastasis via MMP-14
por: Roth, Eric, et al.
Publicado: (2015)

Regulation of miR-181a expression in T cell aging
por: Ye, Zhongde, et al.
Publicado: (2018)

The expression and role of miR-181a in multiple myeloma
por: Yuan, Ruili, et al.
Publicado: (2018)

MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
por: Marisetty, Anantha, et al.
Publicado: (2020)

miR-200a-3p- and miR-181-5p-Mediated HOXB5 Upregulation Promotes HCC Progression by Transcriptional Activation of EGFR
por: Li, Weizhi, et al.
Publicado: (2022)

miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer
por: Liu, Xiaoli, et al.
Publicado: (2019)

miR-424-3p Contributes to the Malignant Progression and Chemoresistance of Gastric Cancer
por: Li, Yongyuan, et al.
Publicado: (2020)

Despite high levels of expression in thymic epithelial cells, miR-181a1 and miR-181b1 are not required for thymic development
por: Stefanski, Heather E., et al.
Publicado: (2018)

miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2
por: Liu, Hui-Ning, et al.
Publicado: (2018)

MiR-326 inhibits trophoblast growth, migration, and invasion by targeting PAX8 via Hippo pathway
por: Zang, Junjie, et al.
Publicado: (2022)

The Inactivation of Hippo Signaling Pathway Promotes the Development of Adenomyosis by Regulating EMT, Proliferation, and Apoptosis of Cells
por: Jin, Tingting, et al.
Publicado: (2023)

MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells
por: Zhai, Xiao-feng, et al.
Publicado: (2013)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6a4kcbi2cikfvpng7untjd09f4